Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives

Overview of attention for article published in Drug Design, Development and Therapy, February 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 59 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 1 news story.

New Targeted Treatments for Differentiated Thyroid Cancer

Medscape, 04 Nov 2022

This transcript has been edited for clarity. Kartik Sehgal, MD: Hello, everyone.